Arkema announced Q1 sales of €1.092 billion. Q1 Ebitda fell by 64 % to €57 million. Visibility remains very low, and the company cannot see any noticeable improvement in the economic environment. Arkema says it confirmed its target to generate a positive free cash flow in 2009 and also confirmed its target to reduce fixed costs by
€550 million in 2010 compared to 2005.
Ineos CEO Ineos calls on European politicians to save the chemical industry.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
